-
Ovid Therapeutics Announces Participation in Two Upcoming Investor Conferences
-
Ovid Therapeutics Inc (OVID) PT Lowered to $8 at Citi
-
Citi Starts Ovid Therapeutics Inc (OVID) at Buy
-
Citi Starts Ovid Therapeutics Inc (OVID) at Buy
-
Ovid Therapeutics (OVID) IPO Opens 7% Lower
-
Ovid Therapeutics Announces Pricing of Initial Public Offering

